| Ulcerative Colitis |
1 |
1 |
| Biologic Therapy |
0 |
0.78 |
| Remission |
0 |
0.98 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.99 |
| Inflammatory Bowel Disease |
0 |
0.52 |
| Colitis |
0 |
0.36 |
| Crohn Disease |
0 |
0.13 |
| Herpes Simplex |
0 |
0.11 |
| Corticosteroids |
0 |
0.09 |
| Cardiovascular Imaging |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Tumor Necrosis Factor-Alpha |
0 |
0.06 |
| Adverse Effects |
0 |
0.04 |
| C-Reactive Protein (CRP) |
0 |
0.04 |
| Comparative Effectiveness |
0 |
0.04 |
| Echocardiography |
0 |
0.04 |
| Fellowship |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Refractory |
0 |
0.04 |
| Tumor |
0 |
0.04 |